Sponsored by Saxo


Good morning everyone, and welcome to 08 April, 2024. The Stockhead team has been hard at work – as usual – and I have once again dived bravely into my browser’s bookmarks, and come up with a bunch of numbers and loads of words, which I’ve included in no particular order down below, so I hope it makes sense.

Beyond all this on Stockhead today, Josh Chiat’s as close as he’s ever going to get to becoming a silver bro, Eddy Sunarto’s discovered some fancy new undies, and Christian Edwards says ‘what’s Chiat on about, guess I’ll have to cover gold then like a proper resources journalist’.



Gold: US$2,285.60 (+0.12%)

Silver: US$25.36 (+0.42%)

Nickel (3mth): US$16,975.00/t (+2.71%)

Copper (3mth): US$9,053.85/t (+1.86%)

Oil (WTI): US$85.11 (+0.06%)

Oil (Brent): US$88.95 (+0.03%)

Iron 62pc Fe: US$102.91/t (+0.56%)

AUD/USD: 0.6516 (+0.05%)

Bitcoin: US$66,252.30 (+1.15%)



Rob Badman’s conjured up more Resources madness, and this time it’s got a picture of a robot on it. Well.. kind of a robot. You’ll see…



Here are the best performing ASX small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort:

Wordpress Table Plugin


Friday’s Small Cap Winners included:

The big news for Friday came via Regeneus (ASX:RGS), after it announced that it has successfully completed a big merger with Cambium Medical Technologies, sending Regeneous shares up +180%. The merger will also see a name change for the entity, and there’s been paperwork lodged with the ASX to rebrand to Cambium Bio (ASX:CBL), while work on the company’s leading collaboration, the development of Elate Ocular, a novel biologic for dry eye disease, continues.

Elixir Energy (ASX:EXR) also had a solid day, revealing that the company decided to test the free-flowing capacity of the Lorelle Sandstone between 4,200 and 4,217 metres, following a recent successful suite of Diagnostic Formation Integrity Tests (DFITs) conducted at Daydream-2. The fresh testing has been deemed a success, with a maximum rate of 2.3 Million Standard Cubic Feet Per Day (MMSCFPD) and stabilised flow rate of 1.3 MMSCFPD (through a 20/64 choke), which the company understands is the deepest unstimulated flow of gas in onshore Australia East of the Perth Basin.

And Biotron (ASX:BIT) has dropped some happy-happy news on the market, announcing that preliminary analyses of data from the BIT225-010 Phase 2 clinical trial of the company’s lead antiviral drug BIT225 provide confirmation, and extension, of the positive results of previous trials in people infected with HIV-1.

Estrella Resources (ASX:ESR) announced that results from initial rock-chip samples are in, which the company says were taken before the granting of Exploration and Evaluation Licences and Reconnaissance Permits for ESR in Timor-Leste. The samples were then brought back to Australia for further analysis. And that turned up an assay result of 60.8% manganese – one of four samples taken during initial limited reconnaissance. Estrella also notes that multiple manganese exposures have been documented across the 503.7km2 leases in Lautém with no modern exploration undertaken.



Here are the worst performing ASX small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort:

Wordpress Table Plugin



Bulletin Resources (ASX:BNR) – pending an announcement in relation to an update on its Ravensthorpe lithium project.

Alice Queen (ASX:AQX) – pending an announcement by the Company to the market regarding a strategic capital raising.

Coolabah Metals (ASX:CBH) – pending an announcement regarding a material capital raising.